GoodRx Holdings, Inc. announced the election of Ronald E. Bruehlman to its Board of Directors, effective November 8, 2024. Mr. Bruehlman brings 39 years of finance experience across the healthcare services, industrial, and petroleum industries.
His appointment is expected to strengthen the company's financial oversight and strategic planning. Mr. Bruehlman currently serves as Chief Financial Officer of IQVIA, a global provider of advanced analytics and clinical research services.
This addition to the board reflects GoodRx's ongoing efforts to enhance its leadership and expertise. The company aims to leverage his extensive experience in navigating complex financial landscapes within the healthcare sector.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.